Docoh
Loading...

20 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
and Senior Financial Analyst, based in Hong Kong, for Darier Henstch, S.A., a private Swiss bank, where he managed their $400 million Asian investment … , a regional Asian investment bank. Mr. Yorke was a Vice President and Senior Financial Analyst with Unifund Global Ltd., a private Swiss Bank
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
Analyst, based in Hong Kong, for Darier Henstch, S.A., a private Swiss bank, where he managed their $400 million Asian investment portfolio. Mr … . Yorke was an Assistant Director and Senior Financial Analyst with Peregrine Asset Management, which was a unit of Peregrine Securities, a regional Asian
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
in Hong Kong, for Darier Henstch, S.A., a private Swiss bank, where he managed their $400 million Asian investment portfolio. Mr. Yorke was an Assistant … Director and Senior Financial Analyst with Peregrine Asset Management, which was a unit of Peregrine Securities, a regional Asian investment bank. Mr
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
managed their $400 million Asian investment portfolio. Mr. Yorke was an Assistant Director and Senior Financial Analyst with Peregrine Asset Management … , which was a unit of Peregrine Securities, a regional Asian investment bank. Mr. Yorke was a Vice President and Senior Financial Analyst with Unifund
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
managed their $400 million Asian investment portfolio. Mr. Yorke was an Assistant Director and Senior Financial Analyst with Peregrine Asset Management … , which was a unit of Peregrine Securities, a regional Asian investment bank. Mr. Yorke was a Vice President and Senior Financial Analyst with Unifund
S-1/A
at0o10vmikw9k
17 Jul 20
IPO registration (amended)
5:25pm
10-K
igrro
5 Mar 20
Annual report
7:00pm
S-1
tfzrjd8fg
13 Dec 19
IPO registration
5:32pm
DEF 14A
u6htqwm
26 Apr 19
Definitive proxy
5:02pm
10-K/A
c8r51hrm5hd 7v
5 Apr 19
Annual report (amended)
9:40pm
10-K
i5zsgo
28 Mar 19
Annual report
5:25pm
424B3
3d8czr
9 Nov 18
Prospectus supplement
5:04pm
S-1/A
7lhbtr1u9e8ie4h
30 Oct 18
IPO registration (amended)
4:19pm
S-1/A
cdcyig krbws
9 Oct 18
IPO registration (amended)
5:32pm
S-1/A
xktg2r7ew
13 Sep 18
IPO registration (amended)
8:00pm
S-1
1n6 vf2ufr
29 Jul 18
IPO registration
8:00pm
10-K/A
fdxc1 ulu3ls
16 Apr 18
Annual report (amended)
8:00pm
10-K
6d4y zpet
15 Apr 18
Annual report
8:00pm
8-K/A
1x7w5o5aoeo1adsjdd9
16 Oct 17
Entry into a Material Definitive Agreement
8:00pm
8-K
rahralx
11 Oct 17
Entry into a Material Definitive Agreement
8:00pm
  • 1